These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25890027)

  • 41. Multiple antiphospholipid tests do not increase the diagnostic yield in antiphospholipid syndrome.
    Bertolaccini ML; Roch B; Amengual O; Atsumi T; Khamashta MA; Hughes GR
    Br J Rheumatol; 1998 Nov; 37(11):1229-32. PubMed ID: 9851275
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effectiveness and safety of selective and non - selective factor Xa inhibitors in antiphospholipid syndrome and systemic lupus erythematosus: anti - Xa - activity range].
    Seredavkina NV; Reshetnyak TM; Satybaldyeva MA; Kashnikova LN; Temnikova TA; Nasonov EL
    Ter Arkh; 2019 May; 91(5):19-25. PubMed ID: 32598672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndrome.
    Amengual O; Atsumi T; Khamashta MA; Koike T; Hughes GR
    Br J Rheumatol; 1996 Dec; 35(12):1239-43. PubMed ID: 9010050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biosensor analysis of beta2-glycoprotein I-reactive autoantibodies: evidence for isotype-specific binding and differentiation of pathogenic from infection-induced antibodies.
    Metzger J; von Landenberg P; Kehrel M; Buhl A; Lackner KJ; Luppa PB
    Clin Chem; 2007 Jun; 53(6):1137-43. PubMed ID: 17434906
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autoantibodies against galectins are associated with antiphospholipid syndrome in patients with systemic lupus erythematosus.
    Sarter K; Janko C; André S; Muñoz LE; Schorn C; Winkler S; Rech J; Kaltner H; Lorenz HM; Schiller M; Andreoli L; Manfredi AA; Isenberg DA; Schett G; Herrmann M; Gabius HJ
    Glycobiology; 2013 Jan; 23(1):12-22. PubMed ID: 22887862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
    Salazar-Páramo M; Jara LJ; Ramos A; Barile L; Machado G; García-De La Torre I
    Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pilot study of anti-mitochondrial antibodies in antiphospholipid syndrome.
    Becker YL; Julien AS; Godbout A; Boilard É; Fortin PR
    Lupus; 2020 Oct; 29(12):1623-1629. PubMed ID: 32787553
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibodies against the N-terminal domain of annexin A2 in antiphospholipid syndrome.
    Salle V; Mazière JC; Brulé A; Schmidt J; Smail A; Duhaut P; Mazière C; Makdassi R; Choukroun G; Betsou F; Ducroix JP
    Eur J Intern Med; 2012 Oct; 23(7):665-8. PubMed ID: 22939813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibodies to endothelial cells and to beta 2-glycoprotein I in the antiphospholipid syndrome: prevalence and isotype distribution.
    Navarro M; Cervera R; Teixidó M; Reverter JC; Font J; López-Soto A; Monteagudo J; Escolar G; Ingelmo M
    Br J Rheumatol; 1996 Jun; 35(6):523-8. PubMed ID: 8670571
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.
    Parkpian V; Verasertniyom O; Vanichapuntu M; Totemchokchyakarn K; Nantiruj K; Pisitkul P; Angchaisuksiri P; Archararit N; Rachakom B; Ayurachai K; Janwityanujit S
    Clin Rheumatol; 2007 Oct; 26(10):1663-70. PubMed ID: 17332980
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic value of antibodies to phosphatidylserine/prothrombin complex for antiphospholipid syndrome in Chinese patients.
    Zhu L; Li C; Liu N; Yang X; Jia RL; Mu R; Su Y; Li ZG
    Clin Rheumatol; 2017 Feb; 36(2):401-406. PubMed ID: 28050648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria.
    Litvinova E; Darnige L; Kirilovsky A; Burnel Y; de Luna G; Dragon-Durey MA
    Front Immunol; 2018; 9():2971. PubMed ID: 30619328
    [No Abstract]   [Full Text] [Related]  

  • 55. Antibodies to age-β2 glycoprotein I in patients with anti-phospholipid antibody syndrome.
    Sorice M; Buttari B; Capozzi A; Profumo E; Facchiano F; Truglia S; Recalchi S; Alessandri C; Conti F; Misasi R; Valesini G; Riganò R
    Clin Exp Immunol; 2016 May; 184(2):174-82. PubMed ID: 26702877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study.
    Sciascia S; Radin M; Cecchi I; Rubini E; Scotta A; Rolla R; Montaruli B; Pergolini P; Mengozzi G; Muccini E; Baldovino S; Ferro M; Vaccarino A; Mahler M; Menegatti E; Roccatello D
    Front Immunol; 2019; 10():376. PubMed ID: 30891041
    [No Abstract]   [Full Text] [Related]  

  • 58. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients.
    López-Soto A; Cervera R; Font J; Bové A; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ordinas A; Ingelmo M
    Clin Exp Rheumatol; 1997; 15(2):143-9. PubMed ID: 9196865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extended Antiphospholipid Antibodies Screening in Systemic Lupus Erythematosus Patients.
    Dima A; Caraiola S; Jurcut C; Balanescu E; Balanescu P; Ramba D; Badea C; Pompilian V; Ionescu R; Baicus A; Baicus C; Dan GA
    Rom J Intern Med; 2015; 53(4):321-8. PubMed ID: 26939208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.